메뉴 건너뛰기




Volumn 44, Issue 2, 2015, Pages 471-480

Tolerability and safety of souvenaid in patients with mild Alzheimer's disease: Results of multi-center, 24-week, open-label extension study

(13)  Olde Rikkert, Marcel G M a   Verhey, Frans R b   Blesa, Rafael c   Von Arnim, Christine A F d   Bongers, Anke e   Harrison, John f,l   Sijben, John e   Scarpini, Elio g   Vandewoude, Maurits F J h   Vellas, Bruno i   Witkamp, Renger j   Kamphuis, Patrick J G H e   Scheltens, Philip k  


Author keywords

Alzheimer's disease; clinical trial; dietary management; intervention studies; long term; medical nutrition therapy; memory; patient adherence; safety

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; ICOSAPENTAENOIC ACID; MINERAL; PHOSPHOLIPID; PYRIDOXINE; SELENIUM; TRACE ELEMENT; URIDINE PHOSPHATE; VITAMIN; FATTY ACID; NOOTROPIC AGENT;

EID: 84921519613     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141305     Document Type: Article
Times cited : (53)

References (28)
  • 1
    • 0037174618 scopus 로고    scopus 로고
    • Alzheimer's disease is a synaptic failure
    • Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
    • (2002) Science , vol.298 , pp. 789-791
    • Selkoe, D.J.1
  • 2
    • 0025987048 scopus 로고
    • Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
    • Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
    • (1991) Ann Neurol , vol.30 , pp. 572-580
    • Terry, R.D.1    Masliah, E.2    Salmon, D.P.3    Butters, N.4    Deteresa, R.5    Hill, R.6    Hansen, L.A.7    Katzman, R.8
  • 3
    • 84897954510 scopus 로고    scopus 로고
    • Is synaptic loss a unique hallmark of Alzheimer's disease?
    • Scheff SW, Neltner JH, Nelson PT (2014) Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 88, 517-528.
    • (2014) Biochem Pharmacol , vol.88 , pp. 517-528
    • Scheff, S.W.1    Neltner, J.H.2    Nelson, P.T.3
  • 5
    • 0025269152 scopus 로고
    • Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
    • DeKosky ST, Scheff SW(1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27, 457-464.
    • (1990) Ann Neurol , vol.27 , pp. 457-464
    • Dekosky, S.T.1    Scheff, S.W.2
  • 6
    • 33646592555 scopus 로고    scopus 로고
    • Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
    • Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088, 83-92.
    • (2006) Brain Res , vol.1088 , pp. 83-92
    • Wurtman, R.J.1    Ulus, I.H.2    Cansev, M.3    Watkins, C.J.4    Wang, L.5    Marzloff, G.6
  • 7
    • 36049020643 scopus 로고    scopus 로고
    • Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus
    • Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182, 50-59.
    • (2007) Brain Res , vol.1182 , pp. 50-59
    • Sakamoto, T.1    Cansev, M.2    Wurtman, R.J.3
  • 8
    • 55549148744 scopus 로고    scopus 로고
    • Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils
    • Holguin S, Martinez J, Chow C, Wurtman R.(2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 22, 3938-3946.
    • (2008) FASEB J , vol.22 , pp. 3938-3946
    • Holguin, S.1    Martinez, J.2    Chow, C.3    Wurtman, R.4
  • 10
    • 33846304174 scopus 로고    scopus 로고
    • Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat
    • Wang L, Albrecht MA, Wurtman RJ (2007) Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res 1133, 42-48.
    • (2007) Brain Res , vol.1133 , pp. 42-48
    • Wang, L.1    Albrecht, M.A.2    Wurtman, R.J.3
  • 11
    • 0037739814 scopus 로고    scopus 로고
    • Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats
    • de Bruin NM, Kiliaan AJ, deWilde MC, Broersen LM (2003) Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 80, 63-79.
    • (2003) Neurobiol Learn Mem , vol.80 , pp. 63-79
    • De Bruin, N.M.1    Kiliaan, A.J.2    Dewilde, M.C.3    Broersen, L.M.4
  • 17
    • 33747760358 scopus 로고    scopus 로고
    • Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
    • Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27, 1372-1384.
    • (2006) Neurobiol Aging , vol.27 , pp. 1372-1384
    • Scheff, S.W.1    Price, D.A.2    Schmitt, F.A.3    Mufson, E.J.4
  • 21
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.M.6
  • 22
    • 0016823810 scopus 로고
    • "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 24
    • 0033193134 scopus 로고    scopus 로고
    • Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia
    • Gelinas I, Gauthier L, McIntyre M, Gauthier S (1999) Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia. Am J Occup Ther 53, 471-481.
    • (1999) Am J Occup Ther , vol.53 , pp. 471-481
    • Gelinas, I.1    Gauthier, L.2    McIntyre, M.3    Gauthier, S.4
  • 25
    • 0030853775 scopus 로고    scopus 로고
    • Standardization (external and internal) of HPLC assay for plasma homocysteine
    • Kuo K, Still R, Cale S, McDowell I (1997) Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43, 1653-1655.
    • (1997) Clin Chem , vol.43 , pp. 1653-1655
    • Kuo, K.1    Still, R.2    Cale, S.3    McDowell, I.4
  • 26
    • 0034833507 scopus 로고    scopus 로고
    • Measurement of homocysteine and other aminothiols in plasma: Advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine
    • Krijt J, VackovaM, Kozich V. (2001) Measurement of homocysteine and other aminothiols in plasma: Advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 47, 1821-1828.
    • (2001) Clin Chem , vol.47 , pp. 1821-1828
    • Krijt, J.1    Vackova, M.2    Kozich, V.3
  • 27
    • 42749100518 scopus 로고    scopus 로고
    • Cholinesterase inhibitors for Alzheimer's disease
    • Birks J. (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593.
    • (2006) Cochrane Database Syst Rev, CD , pp. CD005593
    • Birks, J.1
  • 28
    • 36148957186 scopus 로고    scopus 로고
    • A review of compliance to treatment in Alzheimer's disease: Potential benefits of a transdermal patch
    • Small G, Dubois B (2007) A review of compliance to treatment in Alzheimer's disease: Potential benefits of a transdermal patch. Curr Med Res Opin 23, 2705-2713.
    • (2007) Curr Med Res Opin , vol.23 , pp. 2705-2713
    • Small, G.1    Dubois, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.